P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3‐21R110.

Autor: Hengeveld, P., Ertem, Y. E., Dubois, J., Mellink, C., van der Kevie‐Kersemaekers, A.‐M., Evers, L., Heezen, K., Kolijn, P. M., Mook, O., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P., Niemann, C., Kater, A., Langerak, A., Levin, M.‐D.
Zdroj: HemaSphere; 2022 Supplement 3, Vol. 6, p508-509, 2p
Databáze: Complementary Index